Research
Risk models and scores for type 2 diabetes: systematic review
BMJ 2011; 343 doi: https://doi.org/10.1136/bmj.d7163 (Published 28 November 2011) Cite this as: BMJ 2011;343:d7163Data supplement
Web Extra
Extra material supplied by the author
Files in this Data Supplement:
- Data Supplement - Details of search strategy
Related articles
- Research Published: 18 March 2009; BMJ 338 doi:10.1136/bmj.b880
- Research Published: 15 January 2010; BMJ 340 doi:10.1136/bmj.b4838
- Research Methods & Reporting Published: 04 June 2009; BMJ 338 doi:10.1136/bmj.b606
- Research Published: 22 May 2008; BMJ 336 doi:10.1136/bmj.39545.585289.25
- Research Methods & Reporting Published: 31 March 2009; BMJ 338 doi:10.1136/bmj.b604
- Research Methods & Reporting Published: 23 February 2009; BMJ 338 doi:10.1136/bmj.b375
- Research Methods & Reporting Published: 28 May 2009; BMJ 338 doi:10.1136/bmj.b605
- Research Published: 18 September 2012; BMJ 345 doi:10.1136/bmj.e5900
- Analysis Published: 13 June 2014; BMJ 348 doi:10.1136/bmj.g3725
- Analysis Published: 15 July 2014; BMJ 349 doi:10.1136/bmj.g4485
- Letter Published: 03 July 2012; BMJ 345 doi:10.1136/bmj.e4357
- Editorial Published: 07 September 2015; BMJ 351 doi:10.1136/bmj.h4717
See more
- FDA approves first over-the-counter blood glucose monitor for diabetesBMJ March 11, 2024, 384 q611; DOI: https://doi.org/10.1136/bmj.q611
- US food manufacturer can say that eating yogurt reduces risk of type 2 diabetes, says FDABMJ March 06, 2024, 384 q569; DOI: https://doi.org/10.1136/bmj.q569
- Scarlett McNally: Preventing obesity is different from curing it—and even more urgentBMJ January 23, 2024, 384 q134; DOI: https://doi.org/10.1136/bmj.q134
- Artificial pancreases for type 1 diabetes: Better access is “watershed moment”—but delivery is keyBMJ January 23, 2024, 384 q102; DOI: https://doi.org/10.1136/bmj.q102
- GLP-1 agonist shortage will last until end of 2024, government warnsBMJ January 05, 2024, 384 q28; DOI: https://doi.org/10.1136/bmj.q28
Cited by...
- Study protocol for development and validation of a single tool to assess risks of stroke, diabetes mellitus, myocardial infarction and dementia: DemNCD-Risk
- External validation of the risk prediction model for early diabetic kidney disease in Taiwan population: a retrospective cohort study
- Oral glucose tolerance testing as a complement to fasting plasma glucose in screening for type 2 diabetes: population-based cross-sectional analyses of 146 000 health examinations in Västerbotten, Sweden
- Predictive value of circulating NMR metabolic biomarkers for type 2 diabetes risk in the UK Biobank study
- Prediction of type 2 diabetes mellitus onset using logistic regression-based scoreboards
- Random forest approach for determining risk prediction and predictive factors of type 2 diabetes: large-scale health check-up data in Japan
- Predictive utilities of lipid traits, lipoprotein subfractions and other risk factors for incident diabetes: a machine learning approach in the Diabetes Prevention Program
- COVID-19 risk score as a public health tool to guide targeted testing: A demonstration study in Qatar
- Interpretable Machine Learning Framework Reveals Robust Gut Microbiome Features Associated With Type 2 Diabetes
- Estimating youth diabetes risk using NHANES data and machine learning
- Prediction of type 2 diabetes risk in people with non-diabetic hyperglycaemia: model derivation and validation using UK primary care data
- Performance and costs of multiple screening strategies for type 2 diabetes: two population-based studies in Shanghai, China
- Addressing practical issues of predictive models translation into everyday practice and public health management: a combined model to predict the risk of type 2 diabetes improves incidence prediction and reduces the prevalence of missing risk predictions
- FINDRISC in Latin America: a systematic review of diagnosis and prognosis models
- Can risk be predicted? An umbrella systematic review of current risk prediction models for cardiovascular diseases, diabetes and hypertension
- Machine Learning to Predict the Risk of Incident Heart Failure Hospitalization Among Patients With Diabetes: The WATCH-DM Risk Score
- Risk models and scores for metabolic syndrome: systematic review protocol
- Predicting long-term Type 2 Diabetes with Support Vector Machine using Oral Glucose Tolerance Test
- Derivation and external validation of a clinical version of the German Diabetes Risk Score (GDRS) including measures of HbA1c
- HAPT2D: high accuracy of prediction of T2D with a model combining basic and advanced data depending on availability
- Diabetes Risk Assessment in Latinas: Effectiveness of a Brief Diabetes Risk Questionnaire for Detecting Prediabetes in a Community-Based Sample
- Incremental predictive value of screening for anxiety and depression beyond current type 2 diabetes risk models: a prospective cohort study
- Impact of Lifestyle and Metformin Interventions on the Risk of Progression to Diabetes and Regression to Normal Glucose Regulation in Overweight or Obese People With Impaired Glucose Regulation
- Preventing type 2 diabetes: systematic review of studies of cost-effectiveness of lifestyle programmes and metformin, with and without screening, for pre-diabetes
- Identifying risk for type 2 diabetes in different age cohorts: does one size fit all?
- Systematic review of prognostic prediction models for acute kidney injury (AKI) in general hospital populations
- International Variation in Outcomes Among People with Cardiovascular Disease or Cardiovascular Risk Factors and Impaired Glucose Tolerance: Insights from the NAVIGATOR Trial
- Use of Biomarkers in Predicting the Onset, Monitoring the Progression, and Risk Stratification for Patients with Type 2 Diabetes Mellitus
- Decision tree-based modelling for identification of potential interactions between type 2 diabetes risk factors: a decade follow-up in a Middle East prospective cohort study
- Ethnic differences in prediabetes and diabetes in the Suriname Health Study
- Change in fasting plasma glucose and incident type 2 diabetes mellitus: results from a prospective cohort study
- Racial Differences in the Performance of Existing Risk Prediction Models for Incident Type 2 Diabetes: The CARDIA Study
- Different type 2 diabetes risk assessments predict dissimilar numbers at 'high risk: a retrospective analysis of diabetes risk-assessment tools
- Time to question the NHS diabetes prevention programme
- Validating prediction scales of type 2 diabetes mellitus in Spain: the SPREDIA-2 population-based prospective cohort study protocol
- Sixty-Five Common Genetic Variants and Prediction of Type 2 Diabetes
- The NHS Health Check programme: implementation in east London 2009-2011
- A history of diabetes but not hyperglycaemia during exacerbation of obstructive lung disease has impact on long-term mortality: a prospective, observational cohort study
- Long-term mortality after community-acquired pneumonia--impacts of diabetes and newly discovered hyperglycaemia: a prospective, observational cohort study
- The epidemic of pre-diabetes: the medicine and the politics
- Evidence based medicine: a movement in crisis?
- Clinical and Genetic Determinants of Progression of Type 2 Diabetes: A DIRECT Study
- Protocol for an HTA report: Does therapeutic writing help people with long-term conditions? Systematic review, realist synthesis and economic modelling
- Biomarkers for Type 2 Diabetes and Impaired Fasting Glucose Using a Nontargeted Metabolomics Approach
- Estimating the Population Prevalence of Diagnosed and Undiagnosed Diabetes
- Genetic Information and the Prediction of Incident Type 2 Diabetes in a High-Risk Multiethnic Population: The EpiDREAM genetic study
- Genetic Screening for the Risk of Type 2 Diabetes: Worthless or valuable?
- Recommendations on screening for type 2 diabetes in adults
- Quantifying the risk of type 2 diabetes in East London using the QDScore: a cross-sectional analysis
- Prediction models for risk of developing type 2 diabetes: systematic literature search and independent external validation study
- Should we screen for type 2 diabetes? No
- Time to compare impact and feasibility of prediction models in real life
- Feasibility study of geospatial mapping of chronic disease risk to inform public health commissioning